EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐cell transcriptomics identify TNFRSF1B as a novel T‐cell exhaustion marker for ovarian cancer

Yan Gao iD, Hui Shi, Hongyu Zhao, Mengcheng Yao, Yue He, Mei Jiang, Jie Li, Zhefeng Li, Shaofei Su, Tao Liu, Chenghong Yin, Xuebin Liao und 1 weitere

Clinical and Translational Medicine · 2023-09 · 13 (9)

DOI: 10.1002/ctm2.1416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 15.09.2023. Verfasst von Yan Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing,…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Transcriptome. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ovarian cancer (OC) patients routinely show poor immunotherapeutic response due to the complex tumour microenvironment (TME). It is urgent to explore new immunotherapeutic markers.

Methods

Through the single‐cell RNA sequencing (scRNA‐seq) analyses on high‐grade serous OC (HGSOC), moderate severity borderline tumour and matched normal ovary, we identified a novel exhausted T cells subpopulation that related to poor prognosis in OC. Histological staining, multiple immunofluorescences, and flow cytometry were applied to validate some results from scRNA‐seq. Furthermore, a tumour‐bearing mice model was constructed to investigate the effects of TNFRSF1B treatment on tumour growth in vivo.

Results

Highly immunosuppressive TME in HGSOC is displayed compared to moderate severity borderline tumour and matched normal ovary. Subsequently, a novel exhausted subpopulation of CD8 + TNFRSF1B + T cells is identified, which is associated with poor survival. In vitro experiments demonstrate that TNFRSF1B is specifically upregulated on activated CD8 + T cells and suppressed interferon‐γ secretion. The expression of TNFRSF1B on CD8 + T cells is closely related to OC clinical malignancy and is a marker of poor prognosis through 140 OC patients’ verification. In addition, the blockade of TNFRSF1B inhibits tumour growth via profoundly remodeling the immune microenvironment in the OC mouse model.

Conclusions

Our transcriptomic results analyzed by scRNA‐seq delineate a high‐resolution snapshot of the entire tumour ecosystem of OC TME. The major applications of our findings were an exhausted subpopulation of CD8 + TNFRSF1B + T cells for predicting OC patient prognosis and the potential therapeutic value of TNFRSF1B. These findings demonstrated the clinical value of TNFRSF1B as a potential immunotherapy target and extended our understanding of factors contributing to immunotherapy failure in OC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsTranscriptomeAnimalsFemaleHumansMiceCD3 ComplexCD8-Positive T-LymphocytesEcosystemReceptors, Tumor Necrosis Factor, Type IIT-Cell ExhaustionTumor Microenvironment

Stichwörter der Autor:innen

Ovarian cancerTNFRSF1Bsingle-cell RNA-seqtumour microenvironment

Substanzen

CD3 ComplexReceptors, Tumor Necrosis Factor, Type IITNFRSF1B protein, humanTnfrsf1b protein, mouse

Autor:innen und Institutionen

  • Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.
  • School of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Human Brain Protection, Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Tsinghua University, Beij…
  • Joint Graduate Program of Peking-Tsinghua-NIBS, School of Life Sciences, Tsinghua University, Beijing, China.
  • Bioinformatics department, Annoroad Gene Technology Co., Ltd, Beijing, China.
  • Department of Gynecology and Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.
  • Department of Internal Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.

ORCID-Profile: Yan Gao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Gao, Y., Shi, H., Zhao, H., Yao, M., He, Y., Jiang, M., Li, J., Li, Z., Su, S., Liu, T., Yin, C., Liao, X., & Yue, W. (2023). Single‐cell transcriptomics identify TNFRSF1B as a novel T‐cell exhaustion marker for ovarian cancer. Clinical and Translational Medicine, 13(9). https://doi.org/10.1002/ctm2.1416

Vancouver

Gao Y, Shi H, Zhao H, Yao M, He Y, Jiang M, et al. Single‐cell transcriptomics identify TNFRSF1B as a novel T‐cell exhaustion marker for ovarian cancer. Clinical and Translational Medicine. 2023;13(9). doi:10.1002/ctm2.1416

BibTeX
@article{Gao2023,
  author = {Gao, Yan and Shi, Hui and Zhao, Hongyu and Yao, Mengcheng and He, Yue and Jiang, Mei and Li, Jie and Li, Zhefeng and Su, Shaofei and Liu, Tao and Yin, Chenghong and Liao, Xuebin and Yue, Wentao},
  title = {Single‐cell transcriptomics identify TNFRSF1B as a novel T‐cell exhaustion marker for ovarian cancer},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  volume = {13},
  number = {9},
  doi = {10.1002/ctm2.1416}
}
Kostenlos starten →